Literature DB >> 15122087

Gastro-intestinal hormones GIP and GLP-1.

T J Kieffer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15122087     DOI： 10.1016/s0003-4266(04)95625-9

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN： 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  6 in total

1.  A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.

Authors:  Meixia Dan; Janet K Chantler
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge.

Authors:  Chiara Dalla Man; Francesco Micheletto; Matheni Sathananthan; Adrian Vella; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2016-01       Impact factor: 6.118

3.  Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).

Authors:  Meera Shah; Marcello C Laurenti; Chiara Dalla Man; Jing Ma; Claudio Cobelli; Robert A Rizza; Adrian Vella
Journal:  Metabolism       Date:  2018-12-23       Impact factor: 8.694

Review 4.  The WNT signalling pathway and diabetes mellitus.

Authors:  T Jin
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

5.  Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.

Authors:  Sakura Kiyobayashi; Takaaki Murakami; Norio Harada; Hiroyuki Fujimoto; Yuki Murata; Naotaka Fujita; Keita Hamamatsu; Eri Ikeguchi-Ogura; Tomonobu Hatoko; Xuejing Lu; Shunsuke Yamane; Nobuya Inagaki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

6.  Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.

Authors:  Meera Shah; Jennie H Law; Francesco Micheletto; Matheni Sathananthan; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Michael Camilleri; Alan R Zinsmeister; Adrian Vella
Journal:  Diabetes       Date:  2013-10-02       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.